Review: Mechanotransduction in ovarian cancer: Shearing into the unknown
Ovarian cancer remains a deadly diagnosis with an 85% recurrence rate and a 5-year survival rate of only 46%. The poor outlook of this disease has improved little over the past 50 years owing to the lack of early detection, chemoresistance...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIP Publishing LLC
2018-09-01
|
| Series: | APL Bioengineering |
| Online Access: | http://dx.doi.org/10.1063/1.5024386 |